Observational studyFrontiers in endocrinology2026
iGlarlixi for the simplification of more complex insulin regimens in type 2 diabetes patients with good glycaemic control.
Zoltán J Taybani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.